Gyulladásgátló gyógyszerek

A comprehensive review of non-steroidal anti-inflammatory drug use in the elderly.

Aging Dis. Mechanism of action of non-steroidal anti-inflammatory drugs. Gyulladásgátló gyógyszerek J Med. Application of topical non-steroid anti-inflammatory drugs in rheumatological pain izületi problémák megelőzése. Recommendations for the use of selective and nonselective nonsteroidal antiinflammatory drugs: an American College of Rheumatology White paper.

Arthritis Rheum. Clinical pharmacokinetics of piroxicam.

J Rheumatol. The World Health Organisation analgesic ladder: its place in modern Irish medical practice. Ir Med J. Pain Med. The appropriate use of non-steroidal anti-inflammatory drugs in rheumatic disease: opinions of multidisciplinary European expert panel. Ann Rheum Dis. Anti-inflammatory and upper gastrointestinal effects of celecoxib in rheumatoid arthritis: a randomized controlled trial.

JAMA ; — Gastrointestinal toxicity with celecoxib vs nonsteroidal anti-inflammatory drugs for osteoarthritis and rheumatoid arthritis: the CLASS study.

A gyulladáscsökkentőkről

A randomized controlled trial. Celecoxib Long-term Arthritis Safety Study. Inhibition of human colon cancer cell growth by selective inhibition of cyclooxygenase J Clin Invest.

Safety risks for patients with aspirin-exacerbated respiratory disease after acute exposure to selective nonsteroidal anti-inflammatory drugs and COX-2 inhibitors: Meta-analysis of controlled clinical trials.

J Allergy Clin Immunol.

• Hatásukat egy úgynevezett ciklooxigenáz COX nevű enzim gátlásával fejtik ki.
• Ha lázam van, beveszek egy lázcsillapítót, ha fáj a fejem, egy fájdalomcsillapítót, ha pedig az ízületi gyulladás okoz panaszt, akkor egy gyulladáscsökkentőt.
• Meddig kell szedni a glükozamint kondroitinnel

Role of prostacyclin in the cardiovascular response to thromboxane A2. Science ; — Cardiovascular risk and inhibition of cyclooxygenase: a systematic review of gyulladásgátló gyógyszerek observational studies of selective and nonselective inhibitors of cyclooxygenase 2.

Risk of myocardial infarction in patients taking cyclo-oxygenase-2 inhibitors or gyulladásgátló gyógyszerek non-steroidal anti-inflammatory drugs: population based nested case-control analysis.

Gyulladáscsökkentő krémek és gyógyszerek: külsőleg vagy belsőleg hatékonyabbak?

BMJ ; Vascular and upper gastrointestinal effects of non-steroidal anti-inflammatory drugs: meta-analyses of individual participant data from randomised trials. Lancet ; — Cardiovascular safety of celecoxib, naproxen, or ibuprofen for arthritis.

N Engl J Med. Duration of treatment with nonsteroidal anti-inflammatory drugs and impact on risk of death and recurrent myocardial infarction in patients with prior myocardial infarction: a nationwide cohort study.

Fogyaszd ezeket az ételeket, hogy méregtelenítsd a májad!

Circulation ; — Cardiovascular outcomes with etoricoxib and diclofenac in patients with osteoarthritis and rheumatoid arthritis in the Multinational Etoricoxib and Diclofenac Arthritis Long-term MEDAL programme: a randomised comparison.

Cochrane Database Syst Rev. Polypharmacy in elderly: a cautious trail to tread.

J Pak Med Assoc. Individual non-steroidal anti-inflammatory drugs and risk of acute kidney injury: a systematic review and meta-analyses of observational studies. Eur J Intern Med. Pharmacodynamic interaction of naproxen with low-dose aspirin in healthy subjects. J Am Coll Cardiol.

Fájdalomcsillapító és gyulladáscsökkentők

Cardiovascular outcomes in high risk patients with osteoarthritis treated with ibuprofen, naproxen or lumiracoxib.

Peroral and transdermal application of non-steroidal anti-inflammatory drugs NSAIDs for the treatment of regional musculoskeletal pain syndromes. Tollerabilità dei FANS: recenti acquisizioni.